Although some studies showed that tDCS can induce an increase in serum BDNF levels in opioid-addicted patients [13] or in patients with Parkinson’s disease [14], others did not detect any effects of tDCS on BDNF levels in patients with major depressive disorder [15,16] and bipolar disorder [17]. The gene discussed is BDNF; the disease is Parkinson disease.